S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The “Perfect Storm” for Gold (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
The only accurate crypto trading system I know … (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
Urgent alert: open this for a huge profit potential (Ad)
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The “Perfect Storm” for Gold (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
The only accurate crypto trading system I know … (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
Urgent alert: open this for a huge profit potential (Ad)
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The “Perfect Storm” for Gold (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
The only accurate crypto trading system I know … (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
Urgent alert: open this for a huge profit potential (Ad)
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The “Perfect Storm” for Gold (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
The only accurate crypto trading system I know … (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
Urgent alert: open this for a huge profit potential (Ad)
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
Free Trial

Landos Biopharma (LABP) Earnings Date, Estimates & Call Transcripts

→ You’re invited: Biggest crypto event of 2024 (From InvestorPlace) (Ad)
Free LABP Stock Alerts
$21.76
+0.09 (+0.42%)
(As of 04/18/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
May. 10Estimated
Actual EPS
(Mar. 21)
-$0.99 Missed By -$0.08
Consensus EPS
(Mar. 21)
-$0.91
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

LABP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LABP Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Landos Biopharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($1.12)($0.88)($1.00)
Q2 20242($1.12)($0.63)($0.88)
Q3 20242($1.12)($0.48)($0.80)
Q4 20242($0.53)($0.33)($0.43)
FY 20248($3.89)($2.32)($3.11)

LABP Earnings Date and Information

Landos Biopharma last posted its quarterly earnings results on March 21st, 2024. The reported ($0.99) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.91) by $0.08. Landos Biopharma has generated ($3.46) earnings per share over the last year (($3.46) diluted earnings per share). Earnings for Landos Biopharma are expected to grow in the coming year, from ($2.19) to ($1.68) per share. Landos Biopharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 10th, 2024 based off prior year's report dates.

Landos Biopharma Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/10/2024
Estimated)		------- 
3/21/2024Q4 2023($0.91)($0.99)($0.08)($0.99)--
11/9/2023Q3 2023($0.79)($0.94)($0.15)($0.94)--
8/9/2023Q2 2023($1.10)($0.63)+$0.47($0.63)--
5/12/2023Q1 2023($1.00)($0.90)+$0.10($0.09)--
3/23/2023Q4 2022($1.50)($1.30)+$0.20($0.13)--
11/10/2022Q3 2022($2.90)($2.00)+$0.90($0.20)--
8/11/2022Q2 2022($3.70)($2.80)+$0.90($0.28)--
5/12/2022Q1 2022($3.70)($3.70)-($0.37)--    
3/24/2022Q4 2021($3.00)($5.20)($2.20)($0.52)--
11/15/2021Q3 2021($4.40)($3.20)+$1.20($0.32)--    
7/28/2021Q2 2021($1.40)$1.20+$2.60$0.12$18.00 million$18.00 million
5/16/2021Q1($3.75)($3.80)($0.05)($0.38)--

Landos Biopharma Earnings - Frequently Asked Questions

When is Landos Biopharma's earnings date?

Landos Biopharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 10th, 2024 based off last year's report dates. Learn more on LABP's earnings history.

Did Landos Biopharma beat their earnings estimates last quarter?

In the previous quarter, Landos Biopharma (NASDAQ:LABP) missed the analysts' consensus estimate of ($0.91) by $0.08 with a reported earnings per share (EPS) of ($0.99). Learn more on analysts' earnings estimate vs. LABP's actual earnings.

How much revenue does Landos Biopharma generate each year?

Landos Biopharma (NASDAQ:LABP) has a recorded annual revenue of $18 million.

How much profit does Landos Biopharma generate each year?

Landos Biopharma (NASDAQ:LABP) has a recorded net income of -$21.93 million. LABP has generated -$3.46 earnings per share over the last four quarters.

What is Landos Biopharma's EPS forecast for next year?

Landos Biopharma's earnings are expected to grow from ($2.19) per share to ($1.68) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:LABP) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
The “Perfect Storm” for Gold
Gold Safe Exchange
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Urgent alert: open this for a huge profit potential
Timothy Sykes
The #1 Crypto for 2024
InvestorPlace